
Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Vancomycin resistance Action Pathway (VanB operon)
Staphylococcus aureus
Drug Action Pathway
The VanB-type vancomycin resistance pathway enables enterococcal bacteria to resist the action of the glycopeptide antibiotic vancomycin. This pathway involves a series of genes organized in the VanB operon, which encodes enzymes and regulatory proteins that alter the bacterial cell wall, making it resistant to vancomycin. The operon is made up of 7 genes which can be divided into regulatory (vanR and vanS), resistance (vanH, vanB and vanX) and accessory genes (vanY and vanW). The vanR gene is a response regulator that is part of a two-component regulatory system and activates transcription once phosphorylated by histidine kinase that is encoded by vanS, after detecting vancomycin. The vanH gene encodes an e D-lactate dehydrogenase, which converts pyruvate to D-lactate, a precursor for the altered peptidoglycan precursor (to counteract the effects of vancomycin, which targets the peptidoglycan by binding to D-alanine-D-alanine terminus of the peptide chains, inhibiting cell wall synthesis). A D-Ala-D-Ala dipeptidase, encoded by the vanX gene, hydrolyzes D-Ala-D-Ala dipeptides thus preventing their integration into the peptidoglycan and subsequent peptidoglycan formation in the presence of vancomycin. vanB encodes a D-alanine D-alanine ligase which synthesizes the D-Ala-D-Lac dipeptide that replaces the normal D-Ala-D-Ala in the peptidoglycan precursor, thereby reducing vancomycin's binding affinity. Additionally, the accessory gene vanY, encodes a D,D-carboxypeptidase that, ensures that only D-Ala-D-Lac is used in cell wall synthesis by eliminating the terminal D-alanine residue from peptidoglycan precursors while VanW whose function is unknown.
References
Vancomycin resistance pathway (VanB operon) References
Vo, T., Pontarotti, P., Rolain, J.M. and Merhej, V., 2024. Mechanisms of acquisition of the vanA operon among vancomycin-resistant Staphylococcus aureus genomes: The tip of the iceberg?. International Journal of Antimicrobial Agents, 63(6), p.107154.
Qureshi, N.K., Yin, S. and Boyle-Vavra, S., 2014. The role of the Staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus. PloS one, 9(1), p.e85873.
Hazarika, M., Wangkheimayum, J., Nath, K., Bhowmik, D., Singha, K.M., Chanda, D.D. and Bhattacharjee, A., 2023. Transcriptional Response of van B Operon in Staphylococcus aureus Against Vancomycin and Teicoplanin Stress. Current Microbiology, 80(8), p.275.
Girijan, S.K. and Pillai, D., 2021. Identification and characterization of vancomycin-resistant Staphylococcus aureus in hospital wastewaters: evidence of horizontal spread of antimicrobial resistance. Journal of Water and Health, 19(5), pp.785-795.
Stogios, P.J. and Savchenko, A., 2020. Molecular mechanisms of vancomycin resistance. Protein Science, 29(3), pp.654-669.
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings